These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3327685)

  • 1. Glucose tolerance and secretion and clearance of insulin during long term felodipine treatment.
    Katzman PL; Hulthén UL; Hökfelt B
    Drugs; 1987; 34 Suppl 3():93-4. PubMed ID: 3327685
    [No Abstract]   [Full Text] [Related]  

  • 2. Unchanged insulin secretion and glucose tolerance but increased insulin clearance during long-term calcium antagonism with felodipine in essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    Horm Metab Res; 1987 Sep; 19(9):426-9. PubMed ID: 3319861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felodipine monotherapy in hypertension.
    Littler WA; Smith SA; Mace PJ
    Drugs; 1987; 34 Suppl 3():107-8. PubMed ID: 3443057
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspects on the benefit-risk balance of felodipine in hypertension.
    Elmfeldt D; Westerling S
    Drugs; 1987; 34 Suppl 3():132-5. PubMed ID: 3327674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long term felodipine treatment on renal vascular tone, glomerular filtration rate and renal tubular function in essential hypertension.
    Hulthén UL; Katzman PL; Hökfelt B
    Drugs; 1987; 34 Suppl 3():67-8. PubMed ID: 3443066
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.
    Hedner T; Elmfeldt D; Von Schenck H; Sjögren E; Smith U
    Br J Clin Pharmacol; 1987 Aug; 24(2):145-9. PubMed ID: 3304386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and biochemical effects of the dihydropyridine felodipine in the long term treatment of moderate to severe hypertension.
    Sluiter HE; Huysman FT; Thien TA; Koene RA
    Drugs; 1987; 34 Suppl 3():186-93. PubMed ID: 3443060
    [No Abstract]   [Full Text] [Related]  

  • 8. Short and long term treatment of essential hypertension with felodipine as monotherapy.
    Harrington K; Fitzgerald P; O'Donnell P; Hill KW; O'Brien E; O'Malley K
    Drugs; 1987; 34 Suppl 3():178-85. PubMed ID: 3327679
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium antagonism with felodipine in essential hypertension. Effects on cardiovascular and renal function, the sympathetic and the renin-angiotensin-aldosterone systems, glucose tolerance and glucoregulatory hormones.
    Katzman PL
    Acta Med Scand Suppl; 1987; 720():1-62. PubMed ID: 3328471
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucoregulatory hormone response to insulin-induced hypoglycaemia following long-term calcium antagonism with felodipine in patients with essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):473-8. PubMed ID: 3321819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Felodipine monotherapy in systolic hypertension in the elderly.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Russell AE
    Drugs; 1987; 34 Suppl 3():194-7. PubMed ID: 3327680
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and haemodynamics of felodipine as monotherapy in hypertensive patients.
    Edgar B; Collste P; Haglund K; Regårdh CG
    Drugs; 1987; 34 Suppl 3():28-9. PubMed ID: 3443061
    [No Abstract]   [Full Text] [Related]  

  • 14. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of essential hypertension with felodipine or atenolol as first line therapy. Comparative double-blind randomized study].
    Lesbre JP; Witchitz S; Andrejak M; Morand P; Raveau-Landon C
    Presse Med; 1989 Jan; 18(3):103-6. PubMed ID: 2521934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felodipine versus hydrochlorothiazide as an addition to a beta-blocker in the treatment of hypertension.
    Borgmästars H; Forsén B; Tuomilehto J; Hellebø R; Walle PO; Nielsen HM; Nielsen E; Winkel O; Steiness E; Ibsen H
    Drugs; 1987; 34 Suppl 3():136-8. PubMed ID: 2894972
    [No Abstract]   [Full Text] [Related]  

  • 17. Felodipine versus Moduretic. A double-blind parallel-group multicentre study.
    Krönig B; Flygt G
    Drugs; 1987; 34 Suppl 3():162-9. PubMed ID: 3327677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy with felodipine, a new calcium antagonist, in mild and moderate hypertension.
    Hamilton DV; Barnes PC; Bowles RM; Rajaratnam DV; Comerford MB; Ginks WR; Ginks SE; Goves JR; Grabau WJ; Malcolm JP
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S111-3. PubMed ID: 2455107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-response study of felodipine in patients remaining hypertensive on a beta blocker. Canadian Felodipine Study Group.
    Drugs; 1987; 34 Suppl 3():176-7. PubMed ID: 2894976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.